期刊文献+

透明质酸钠与吡柔比星在预防腺性膀胱炎术后复发效果的比较 被引量:8

Comparison of sodium hyaluronate and pirarubicin for the treatment effects to postoperative cystitis glandularis
原文传递
导出
摘要 目的评价透明质酸钠液在预防腺性膀胱炎术后复发的作用。方法将2010年5月至2013年1月山西省晋中市第一人民医院的73例经尿道等离子电切术后的腺性膀胱炎患者随机分为两组(膀胱内灌注无菌透明质酸钠液37例和吡柔比星注射液36例),对两组的复发率和灌注后膀胱刺激症状的发生率进行比较。结果透明质酸钠组复发率为0%,膀胱刺激症状发生率为0%;而吡柔比星组复发率为25.0%,膀胱刺激症状发生率为88.9%。结论膀胱灌注透明质酸钠液在预防腺性膀胱炎术后复发的疗效和安全性方面优于吡柔比星。 Objective To evaluate the effect of sodium hyaluronate in the prevention of recurrence of cystitis glandularis after transuresical resection.Methods 73 patientis with cystitis guandularis underwent transurethral resection of the plasma from May 2010 to January 2013 were randomly divided into two groups. The first group including 37 patients were injected with intravesical sterile sodium hyaluronate solution. The second group including 36 patients were applied with intravesical Pirarubicin injection. The recurrence rate and incidence of bladder irritation between the two groups were compared after intravesical instillation. Results In the first group, the recurrence rate was 0% and the incidence rate of bladder irritation was 0%. In the second group, the recurrence rate was 25.0% and the incidence rate of bladder irritation was 88.9%. Conclusion In terms of both efficiency and safety in the prevention of postoperative recurrence of patientis with cystitis glandularis, sodium hyaluronate solution was better than Pirarubicin injection.
作者 杨成宇
出处 《中华腔镜泌尿外科杂志(电子版)》 2015年第1期47-49,共3页 Chinese Journal of Endourology(Electronic Edition)
关键词 腺性膀胱炎 透明质酸钠液 吡柔比星 膀胱内灌注 Cystitis glandularis Sodium hyaluronate Pirarubicin Intravesicalinstillation
  • 相关文献

参考文献4

二级参考文献35

  • 1范海涛,周裔,徐文翠,刘禄成.经尿道电切术联合术后表柔比星膀胱灌注治疗腺性膀胱炎(附130例报告)[J].中国微创外科杂志,2008,8(4):329-330. 被引量:10
  • 2徐罡,丁强,孙颖浩,许传亮,黄翼然,薛蔚,夏术阶,凡杰,张元芳.膀胱内灌注透明质酸治疗顽固性非细菌性膀胱炎的多中心观察[J].中华泌尿外科杂志,2006,27(7):483-485. 被引量:10
  • 3余恩念,姜芙蓉,崔明霞,程莹莹.疼痛评分观测记录单的设计与应用[J].中国实用护理杂志(下旬版),2007,23(4):32-32. 被引量:7
  • 4Michael YL, Kawachi I, Stampfer MJ, et al, Quality of life among women with interstitial cystitis. J Urol, 2000, 164: 423-427.
  • 5Rothrock NE, Lutgendorf SK, Kreder KJ. Coping strategies in patients with interstitial cystitis relationships with quality of life and depression. J Urol, 2003, 169: 233-236.
  • 6Morales A, Emerson L, Nickel JC, et al. Intravesieal hyaluronic acid in the treatment of refractory interstitial cystitis. Urology, 1997, 49: 111-113.
  • 7Morales A, Emerson L, Nickel JC, et al. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol, 1996, 156: 45-48.
  • 8O~Leary MP, Sant GR, Fowler FJ Jr, et al. The interstitial cystitis symptom index and problem index. Urology, 1997, 49 : 58-63.
  • 9Baykara M, Erdogru T, Gulkesen KH, et al. Does interstitial cystitis urine include possible factors effecting the nociceptive system of the spinal cord? Urol Int, 2003, 71 : 66-72.
  • 10Parsons CL. The role of the glycosaminoglycan layer in blad der defense mechanisms and interstitial cystitis. Int Urogynecol J, 1993, 4; 373-379.

共引文献72

同被引文献60

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部